Prevalence of HAV among Healthy Blood Donors Referring to Tehran Transfusion Center
Background: Hepatitis A virus (HAV) is a single strand and non-enveloped RNA virus. It is usually transmitted by the fecal-oral and the blood transfusion routes and causes the hepatitis A disease. Clinically, the hepatitis A is usually mild, particularly in children, in whom it is frequently subcl...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2008-12-01
|
Series: | Iranian Journal of Public Health |
Subjects: | |
Online Access: | https://ijph.tums.ac.ir/index.php/ijph/article/view/2025 |
_version_ | 1818884044386992128 |
---|---|
author | A Elikaei Z Sharifi M Mahmoudian Shooshtari M Hosseini Y Maroufi |
author_facet | A Elikaei Z Sharifi M Mahmoudian Shooshtari M Hosseini Y Maroufi |
author_sort | A Elikaei |
collection | DOAJ |
description | Background: Hepatitis A virus (HAV) is a single strand and non-enveloped RNA virus. It is usually transmitted by the fecal-oral and the blood transfusion routes and causes the hepatitis A disease. Clinically, the hepatitis A is usually mild, particularly in children, in whom it is frequently subclinical. The disease is more serious and prolonged in adults. The objective of this study was to find the prevalence of HAV among blood donors in Tehran, Iran.
Methods: Sera of 407 blood donors in Tehran Blood Transfusion Center who were negative for anti-HIV, HBs Ag and anti-HCV were tested for total anti-HAV antibody, anti-HAV IgM and HAV RNA. Total antibodies (IgG+IgM) and IgM were determined by ELISA using commercial kits. HAV RNA was detected by nested RT-PCR.
Results: The prevalence of total anti-HAV antibodies in blood donors were was 86%, and also the ratio 99% of blood donors was negative for anti-HAV IgM and 1% was equivocal. HAV RNA was not found in any serum samples. The prevalence of total anti-HAV antibodies among blood donors was high; it means most of them were infected in childhood. In spite of, 14% of blood donors were negative for total anti-HAV antibodies; the prevalence of anti-HAV IgM and HAV RNA were very low.
Conclusion: Carefully blood donor selection is performed in Iran. |
first_indexed | 2024-12-19T15:43:17Z |
format | Article |
id | doaj.art-532db9257f0b44c09d41818d64475efa |
institution | Directory Open Access Journal |
issn | 2251-6085 2251-6093 |
language | English |
last_indexed | 2024-12-19T15:43:17Z |
publishDate | 2008-12-01 |
publisher | Tehran University of Medical Sciences |
record_format | Article |
series | Iranian Journal of Public Health |
spelling | doaj.art-532db9257f0b44c09d41818d64475efa2022-12-21T20:15:24ZengTehran University of Medical SciencesIranian Journal of Public Health2251-60852251-60932008-12-01374Prevalence of HAV among Healthy Blood Donors Referring to Tehran Transfusion CenterA Elikaei 0Z Sharifi 1M Mahmoudian Shooshtari 2M Hosseini 3Y Maroufi 4Research Center of Iranian Blood Transfusion Organization (IBTO), Tehran, IranResearch Center of Iranian Blood Transfusion Organization (IBTO), Tehran, IranResearch Center of Iranian Blood Transfusion Organization (IBTO), Tehran, Iran Dept. of Microbiology, Faculty of Biological Sciences, Shahid Beheshti University, Tehran, IranResearch Center of Iranian Blood Transfusion Organization (IBTO), Tehran, IranBackground: Hepatitis A virus (HAV) is a single strand and non-enveloped RNA virus. It is usually transmitted by the fecal-oral and the blood transfusion routes and causes the hepatitis A disease. Clinically, the hepatitis A is usually mild, particularly in children, in whom it is frequently subclinical. The disease is more serious and prolonged in adults. The objective of this study was to find the prevalence of HAV among blood donors in Tehran, Iran. Methods: Sera of 407 blood donors in Tehran Blood Transfusion Center who were negative for anti-HIV, HBs Ag and anti-HCV were tested for total anti-HAV antibody, anti-HAV IgM and HAV RNA. Total antibodies (IgG+IgM) and IgM were determined by ELISA using commercial kits. HAV RNA was detected by nested RT-PCR. Results: The prevalence of total anti-HAV antibodies in blood donors were was 86%, and also the ratio 99% of blood donors was negative for anti-HAV IgM and 1% was equivocal. HAV RNA was not found in any serum samples. The prevalence of total anti-HAV antibodies among blood donors was high; it means most of them were infected in childhood. In spite of, 14% of blood donors were negative for total anti-HAV antibodies; the prevalence of anti-HAV IgM and HAV RNA were very low. Conclusion: Carefully blood donor selection is performed in Iran.https://ijph.tums.ac.ir/index.php/ijph/article/view/2025Hepatitis A virus (HAV)Blood donorsPrevalenceIran |
spellingShingle | A Elikaei Z Sharifi M Mahmoudian Shooshtari M Hosseini Y Maroufi Prevalence of HAV among Healthy Blood Donors Referring to Tehran Transfusion Center Iranian Journal of Public Health Hepatitis A virus (HAV) Blood donors Prevalence Iran |
title | Prevalence of HAV among Healthy Blood Donors Referring to Tehran Transfusion Center |
title_full | Prevalence of HAV among Healthy Blood Donors Referring to Tehran Transfusion Center |
title_fullStr | Prevalence of HAV among Healthy Blood Donors Referring to Tehran Transfusion Center |
title_full_unstemmed | Prevalence of HAV among Healthy Blood Donors Referring to Tehran Transfusion Center |
title_short | Prevalence of HAV among Healthy Blood Donors Referring to Tehran Transfusion Center |
title_sort | prevalence of hav among healthy blood donors referring to tehran transfusion center |
topic | Hepatitis A virus (HAV) Blood donors Prevalence Iran |
url | https://ijph.tums.ac.ir/index.php/ijph/article/view/2025 |
work_keys_str_mv | AT aelikaei prevalenceofhavamonghealthyblooddonorsreferringtotehrantransfusioncenter AT zsharifi prevalenceofhavamonghealthyblooddonorsreferringtotehrantransfusioncenter AT mmahmoudianshooshtari prevalenceofhavamonghealthyblooddonorsreferringtotehrantransfusioncenter AT mhosseini prevalenceofhavamonghealthyblooddonorsreferringtotehrantransfusioncenter AT ymaroufi prevalenceofhavamonghealthyblooddonorsreferringtotehrantransfusioncenter |